• The event is a one-on-one analyst/institutional investor meeting.
  • The meeting is scheduled for 20th November, 2026 at 1600 hrs IST.
  • The meeting will be held in person at the Corporate Office, BKC, Mumbai.
  • The stated counterparty for the meeting is Alpha Alternatives.
  • The company explicitly states that no Unpublished Price Sensitive Information (UPSI) will be shared at this meeting.
  • The disclosure is made pursuant to Regulation 30 read with Schedule III Part A Para A of the SEBI (LODR) Regulations, 2015 and relevant SEBI circulars.
  • The document includes a note that the date of the meeting is subject to change.

Additional Notes Section

  • The disclosure is signed by Arvind Patkar, Company Secretary and Compliance Officer (Membership No.: ACS 21577).
  • The document reference number is UTI/AMC/CS/SE/2026-27/0738 and it is dated 16th November, 2026.
  • No financial data, performance figures, guidance, or strategic updates were disclosed in this announcement. The document is purely a scheduling intimation.
  • No information was provided regarding management participants from UTI AMC, presentation materials, or availability of transcripts/recordings.